Get Connected:

 

Latest News

Top 5 Low-Value Services Driving Healthcare Spending
Unnecessary healthcare services cost the United States billions each year.
A ketogenic state may provide benefits for patients with diabetes.
Top news from across the healthcare landscape.
Axicabtagene ciloleucel (Yescarta) indicated for the treatment of adults with diffuse large B-cell lymphoma.
Once-weekly injection of semaglutide recommended for approval for improved glycemic control in adults with type 2 diabetes.
A new Washington Post/60 Minutes interview alleges distributors and legislators are responsible for the opioid epidemic.
Sugar may influence fat metabolism and increase cardiovascular risks.
Newborns administered therapeutic hypothermia were much less likely to develop epilepsy.
View More >

From the Journals

For patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
An examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.
Physician-, payer-, and patient-based organizations are increasingly developing frameworks that measure the value of a treatment and define it in terms of specific target audiences.
Medication compliance is associated with lower overall and disease-related healthcare costs in patients with moderate to severe rheumatoid arthritis receiving biologic therapies.
Clinician and patient understanding and access considerations represent the most significant hurdles inhibiting the uptake of biosimilars for inflammatory conditions.
Specialty pharmacies and managed care organizations will need to work together to truly balance the scale between cost and improved patient outcomes.
The distribution of infusible specialty medications comes with difficulties that must be addressed by pharmacies and payers.
Upcoming Partner Events